GPACTS 2026: Global Pharma AI, Compliance and Technology Summit to Convene in Hyderabad

GPACTS 2026, the Global Pharma AI, Compliance & Technology Summit, is scheduled to bring its flagship edition to the Novotel Hyderabad Convention Centre (HICC) on September 3, 2026. Powered by Honeywell, the summit will convene between 350 and 400 senior decision-makers from pharmaceutical technology, manufacturing, quality, compliance, data, and cybersecurity functions.

The event arrives as pharmaceutical companies accelerate investments in artificial intelligence, connected manufacturing, and data-led operations while facing heightened scrutiny regarding validation, data integrity, cybersecurity, and regulatory compliance. Unlike broad technology conferences, GPACTS focuses specifically on the operational realities of regulated pharmaceutical environments, bringing enterprise technology and business leadership into direct dialogue with manufacturing, quality, and compliance teams.

The Hyderabad agenda will tackle responsible AI and governance in validated environments, evolving data-protection requirements, manufacturing cybersecurity, digital batch processes, manufacturing execution systems, laboratory software, connected quality systems, and digital twins. Confirmed speakers feature distinguished industry figures such as former FDA Director Dr. Ajaz Hussain; Alkem Laboratories VP and CIO Ramanarayana Parhi; Dr. Reddy’s Laboratories Digital Transformation Head Rajesh T; FOPE Chairman AVPS Chakravarty; IPA Honorary Secretary Dr. Sridhar Reddy; Telangana Life Sciences CEO Sarvesh Singh; Wockhardt VP of Quality IT Dr. Deepa Pangaonkar; Granules India CIO Karthick Raja; and Biological E VP of IT Praveen Kumar Baheti, alongside leaders from various pharmaceutical enterprises, technology organizations, and advisory firms.

The Hyderabad flagship is supported by Thermo Fisher Scientific, Rockwell Automation, and Nividous Software. Building on earlier 2026 editions held in Mumbai and Ahmedabad—which engaged 228 delegates and 32 speakers with over 80 percent representing pharma end-user organizations—the summit expands upon practitioner-led formats like live ransomware tabletop simulations to move the industry from ambition to accountable implementation.